Quality Choice Long Acting Cough Softgel Capsule, Liquid Filled
NDC Package 83324-303-20
Package Information
Quality Choice Long Acting Cough Softgel (dextromethorphan hydrobromide) capsules is • do not take more than 8 softgels in any 24-hour period • this adult product is not intended for use in children under 12 years of age adults and children 12 years and older take 2 softgels every 6 to 8 hours, as needed children under 12 years do not use. This formulation utilizes a capsule, liquid filled delivery system. Marketed by Chain Drug Marketing Association, Inc., this product is identified by NDC 83324-303 and is authorized under FDA application M012.
Identification & Billing
- RxCUI: 1090487 - dextromethorphan HBr 15 MG Oral Capsule
- RxCUI: 1090487 - dextromethorphan hydrobromide 15 MG Oral Capsule
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 83324 - Chain Drug Marketing Association, Inc.
- 83324-303 - Quality Choice Long Acting Cough Softgel
- 83324-303-20 - 1 BOTTLE in 1 CARTON / 20 CAPSULE, LIQUID FILLED in 1 BOTTLE
- 83324-303 - Quality Choice Long Acting Cough Softgel
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 83324-303-20 identifies a specific commercial package of 1 bottle in 1 carton / 20 capsule, liquid filled in 1 bottle of Quality Choice Long Acting Cough Softgel, a human over the counter drug labeled by Chain Drug Marketing Association, Inc.. This capsule, liquid filled is formulated for oral use and contains dextromethorphan hydrobromide as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Chain Drug Marketing Association, Inc. on August 16, 2024. The current certification is valid through December 31, 2026.
How is this Chain Drug Marketing Association, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 83324030320. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.